Biocept has developed the Cell Enrichment and Extraction™ (CEE) technology, which utilizes the company’s proprietary system to capture rare cells in a microfluidic device.
Once captured, these cells remain suitable for molecular diagnosis either a
The CEE system has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 5-10 billion blood cells. Examples of these are circulating tumor cells (CTCs) in patients with early-stage, metastatic or r
your company/listing wishes to provide more free information to browsers
including agencies and distributors, areas of speciality, product type
and product lisiting, please contact VL@fertaid.com